Cargando…
中国慢性髓性白血病患者酪氨酸激酶抑制剂治疗现状的调研:从患者的角度
OBJECTIVE: To assess tyrosine kinase inhibitor (TKI) treatment status in patients with chronic myeloid leukemia (CML) in China and analyze the response-associated factors. METHODS: From May to November in 2014, anonymous questionnaires were distributed to adult CML patients who were receiving TKI tr...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365001/ https://www.ncbi.nlm.nih.gov/pubmed/27535854 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.07.004 |